IMMUNE ACTIVATING FC DOMAIN BINDING MOLECULES

The present invention generally relates to novel immune activating Fc domain binding molecules for activation of immune cells and re-direction to specific target cells. In addition, the present invention relates to polynucleotides encoding such molecules, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the bispecific antigen binding molecules of the invention, and to methods of using these bispecific antigen binding molecules in the treatment of disease..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 26. Apr. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

AMANN MARIA [VerfasserIn]
CARPY GUTIERREZ CIRLOS ALEJANDRO [VerfasserIn]
CLAUS CHRISTINA [VerfasserIn]
CODARRI DEAK LAURA [VerfasserIn]
DAROWSKI DIANA [VerfasserIn]
FAUTI TANJA [VerfasserIn]
FERRARA KOLLER CLAUDIA [VerfasserIn]
FREIMOSER-GRUNDSCHOBER ANNE [VerfasserIn]
HERTER SYLVIA [VerfasserIn]
HOFER THOMAS [VerfasserIn]
KLEIN CHRISTIAN [VerfasserIn]
LAUENER LAURA [VerfasserIn]
LECLAIR STEPHANE [VerfasserIn]
MOESSNER EKKEHARD [VerfasserIn]
NEUMANN CHRISTIANE [VerfasserIn]
UMAÑA PABLO [VerfasserIn]
SURÓWKA MARLENA [VerfasserIn]
BRANSI ALI [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
C07K: Peptides (peptides containing β-lactam rings c07d; (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-04-26, Last update posted on www.tib.eu: 2024-01-30, Last updated: 2024-02-02

Patentnummer:

EP4168445

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA016985176